Factors associated with the presence of steatosis
| Absence of steatosis (n=155) | Presence of steatosis (n=135) | p Value | |
|---|---|---|---|
| *Results are expressed as mean (SD). | |||
| BMI, body mass index; ALT, alanine aminotransferase; HCV, hepatitis C virus. | |||
| Sex (male, n (%)) | 73 (52) | 70 (47) | 0.42 |
| Age (n (%)) | 0.04 | ||
| <50 y | 109 (70) | 73 (54) | |
| ⩾50 y | 46 (30) | 62 (46) | |
| Age at infection (n (%)) | 0.21 | ||
| <30 years | 65 (84) | 62 (77) | |
| ⩾30 | 12 (16) | 19 (23) | |
| Source of infection (n (%)) | 0.23 | ||
| Blood transfusion | 33 (21) | 37 (27) | |
| Intravenous drug use | 46 (30) | 45 (33) | |
| Unknown | 76 (49) | 53 (39) | |
| Duration of infection (n=155) (y)* | 19.4 (6.9) | 22.4 (7.6) | 0.01 |
| Body mass index (kg/m2) (n (%)) | 0.003 | ||
| Normal (BMI <25) | 103 (66) | 68 (50) | |
| Overweight (25⩽BMI<30) | 36 (23) | 42 (31) | |
| Obese (BMI ⩾30) | 4 (3) | 16 (12) | |
| Unknown | 12 (8) | 9 (7) | |
| Alcohol consumption (n (%)) | 0.29 | ||
| Absent | 106 (68) | 84 (62) | |
| Present | 43 (28) | 48 (36) | |
| Unknown | 6 (4) | 3 (2) | |
| Tobacco consumption (n (%)) | 0.58 | ||
| Absent | 79 (51) | 75 (56) | |
| Present | 64 (41) | 53 (39) | |
| Unknown | 12 (8) | 7 (5) | |
| ALT (IU/l, median) | 78 (81) | 119 (83) | 0.0001 |
| Glycaemia (mmol/l)* | 5.0 (1.3) | 5.7 (2.1) | 0.002 |
| Cholesterol (mmol/l)* | 4.9 (1.1) | 4.7 (1.0) | 0.18 |
| Triglycerides (mmol/l) (mmol/l)* | 1.1 (0.7) | 1.2 (0.8) | 0.17 |
| HCV genotype (n (%)) | 0.03 | ||
| 3 | 19 (12) | 32 (24) | |
| Other | 114 (74) | 84 (62) | |
| Unknown | 22 (14) | 19 (14) | |
| Grade (histology) (n (%)) | <0.0001 | ||
| A0–A1 | 129 (83) | 83 (61) | |
| A2–A3 | 26 (17) | 52 (39) | |
| Stage (histology) (n (%)) | <0.0001 | ||
| F0–F1 | 111 (72) | 70 (52) | |
| F2–F3–F4 | 44 (28) | 65 (48) | |